These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 9789291)

  • 1. [In vivo study on intrathecal use of 5-fluoro-2'-deoxyuridine (FdUrd) in meningeal dissemination of malignant tumor].
    Nakagawa H; Yamada M; Fukushima M; Shimizu K; Ikenaka K
    No Shinkei Geka; 1998 Oct; 26(10):873-9. PubMed ID: 9789291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal 5-fluoro-2'-deoxyuridine (FdUrd) for the treatment of solid tumor neoplastic meningitis: an in vivo study.
    Nakagawa H; Yamada M; Fukushima M; Ikenaka K
    Cancer Chemother Pharmacol; 1999; 43(3):247-56. PubMed ID: 9923556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro study on intrathecal application of 5-fluoro-2'-deoxyuridine (FdUrd) for meningeal dissemination of malignant tumor].
    Nakagawa H; Yamada M; Fukushima M; Shimizu K; Ikenaka K
    No Shinkei Geka; 1998 Sep; 26(9):787-94. PubMed ID: 9757455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro study on intrathecal use of 5-fluoro-2'-deoxyuridine (FdUrd) for meningeal dissemination of malignant brain tumors.
    Yamada M; Nakagawa H; Fukushima M; Shimizu K; Hayakawa T; Ikenaka K
    J Neurooncol; 1998 Apr; 37(2):115-21. PubMed ID: 9524089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trial of intrathecal administration of 5-fluoro-2'-deoxyuridine for treatment of meningeal dissemination of malignant tumors.
    Nakagawa H; Yamada M; Maeda N; Iwatsuki K; Hirayama A; Ikenaka K
    J Neurooncol; 1999; 45(2):175-83. PubMed ID: 10778733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical application of FdUrd to meningeal dissemination of malignant tumors].
    Nakagawa H; Yamada M; Maeda N; Iwatsuki K; Tsuzuki T; Hirayama A; Yamamoto H; Ikenaka K
    No Shinkei Geka; 1998 Nov; 26(11):969-77. PubMed ID: 9834491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracavitary chemotherapy with 5-fluoro-2'-deoxyuridine (FdUrd) in malignant brain tumors.
    Nakagawa H; Maeda N; Tsuzuki T; Suzuki T; Hirayama A; Miyahara E; Wada K
    Jpn J Clin Oncol; 2001 Jun; 31(6):251-8. PubMed ID: 11463802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between circadian-dependent toxicity of 5-fluorodeoxyuridine and circadian rhythms of pyrimidine enzymes: possible relevance to fluoropyrimidine chemotherapy.
    Zhang R; Lu Z; Liu T; Soong SJ; Diasio RB
    Cancer Res; 1993 Jun; 53(12):2816-22. PubMed ID: 8504424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathecal administration of Y-27632, a specific rho-associated kinase inhibitor, for rat neoplastic meningitis.
    Nakagawa H; Yoshioka K; Miyahara E; Fukushima Y; Tamura M; Itoh K
    Mol Cancer Res; 2005 Aug; 3(8):425-33. PubMed ID: 16123138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intrathecal infusion of the antineoplastic agents for meningeal dissemination].
    Hodozuka A; Hayashi Y; Annei R; Hiroshima S; Saito M; Orimoto R; Sato M; Tanaka T
    Gan To Kagaku Ryoho; 2008 Jun; 35(6):900-5. PubMed ID: 18633217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel combination antimetabolite, TAS-102, exhibits antitumor activity in FU-resistant human cancer cells through a mechanism involving FTD incorporation in DNA.
    Emura T; Suzuki N; Yamaguchi M; Ohshimo H; Fukushima M
    Int J Oncol; 2004 Sep; 25(3):571-8. PubMed ID: 15289858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymidine kinase, thymidylate synthase, and dihydropyrimidine dehydrogenase profiles of cell lines of the National Cancer Institute's Anticancer Drug Screen.
    Grem JL; Danenberg KD; Behan K; Parr A; Young L; Danenberg PV; Nguyen D; Drake J; Monks A; Allegra CJ
    Clin Cancer Res; 2001 Apr; 7(4):999-1009. PubMed ID: 11309351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cytostatic activity of NUC-3073, a phosphoramidate prodrug of 5-fluoro-2'-deoxyuridine, is independent of activation by thymidine kinase and insensitive to degradation by phosphorolytic enzymes.
    Vande Voorde J; Liekens S; McGuigan C; Murziani PG; Slusarczyk M; Balzarini J
    Biochem Pharmacol; 2011 Sep; 82(5):441-52. PubMed ID: 21658373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of potentiation of antitumor activity of 5-fluoro-2'-deoxyuridine in the adenocarcinoma 755 system by guanosine 5'-monophosphate.
    Iigo M; Yamaizumi Z; Nakajima Y; Nishimura S; Hoshi A
    Drugs Exp Clin Res; 1988; 14(4):257-63. PubMed ID: 2458897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous intrathecal administration of 5-fluoro-2'-deoxyuridine for the treatment of neoplastic meningitis.
    Nakagawa H; Miyahara E; Suzuki T; Wada K; Tamura M; Fukushima Y
    Neurosurgery; 2005 Aug; 57(2):266-80; discussion 266-80. PubMed ID: 16094155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Measurements of CSF biochemical tumor markers in patients with meningeal carcinomatosis].
    Nakagawa H; Kubo S; Murasawa A; Nakajima S; Nakajima Y; Izumoto S; Hayakawa T
    No Shinkei Geka; 1991 Dec; 19(12):1135-41. PubMed ID: 1766538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity of ZD1694 (tomudex) against human head and neck cancer in nude mouse models: role of dosing schedule and plasma thymidine.
    Cao S; McGuire JJ; Rustum YM
    Clin Cancer Res; 1999 Jul; 5(7):1925-34. PubMed ID: 10430100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic efficacy of fluoropyrimidines depends on the duration of thymidylate synthase inhibition in the murine colon 26-B carcinoma tumor model.
    van Laar JA; van der Wilt CL; Rustum YM; Noordhuis P; Smid K; Pinedo HM; Peters GJ
    Clin Cancer Res; 1996 Aug; 2(8):1327-33. PubMed ID: 9816304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymidine kinase and thymidine phosphorylase level as the main predictive parameter for sensitivity to TAS-102 in a mouse model.
    Emura T; Nakagawa F; Fujioka A; Ohshimo H; Kitazato K
    Oncol Rep; 2004 Feb; 11(2):381-7. PubMed ID: 14719072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective accumulation of 3',5'-dioctanoyl-5-fluoro-2'-deoxyuridine (FdUrd-C8) and sustained release of its active metabolites in VX-2 rabbit hepatoma following intraarterial administration of FdUrd-C8 solution in Lipiodol.
    Kawaguchi T; Fukushima S; Hayashi Y; Kaneko M; Nakano M
    Cancer Res; 1988 Aug; 48(15):4179-83. PubMed ID: 2839289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.